跳至主要内容
临床试验/NCT07112365
NCT07112365招募中4 期

The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome (FAST-DS) Project.

The University of Texas Health Science Center, Houston1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2026年4月27日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
25
试验地点
1
主要终点
Change in blood oxygenation level in response to CO₂

研究概览

简要总结

This study investigates cerebrovascular reactivity (CVR) and functional brain connectivity in Dravet Syndrome (DS) patients with convulsive seizures. Using functional MRI (fMRI), we will define differences in brain responses to CO₂ changes before administration of the drug Fintepla (Baseline), with a library of healthy controls and with those obtained after administration of Fintepla (Day ~60). Changes in CVR and their relation to ventilatory responses will also be assessed during fMRI.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • DS patients (with or without SCN1A pathogenic mutations)
  • Generalized convulsive seizures

排除标准

  • known cardiorespiratory, hepatic or renal disease, and/or
  • allergic reactions or other contraindications to fenfluramine and/or
  • on Stiripentol treatment, and/or
  • on serotonergic medications, and/or
  • contraindications to Midazolam anesthesia
  • taken the following drugs within 14 days: monoamine oxidase inhibitors (MAOIs), anti-depressants (Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin and norepinephrine reuptake inhibitors (SNRIs), and Tricyclic antidepressants (TCAs)), St. John's Wort, Tryptophan, and Dextromethorphan

结局指标

主要结局

Change in blood oxygenation level in response to CO₂

时间窗: Baseline, Day ~60

Measures how much blood oxygenation level dependent (BOLD) signal changes in response to CO₂, using fMRI.

Change in speed of cerebrovascular response to CO₂

时间窗: Baseline, Day ~60

Measures how quickly the brain responds to CO₂ exposure during fMRI.

次要结局

  • Change in breathing response to CO₂(Baseline, Day ~60)

研究者

发起方
The University of Texas Health Science Center, Houston
申办方类型
Other
责任方
Principal Investigator
主要研究者

Samden Lhatoo

Professor

The University of Texas Health Science Center, Houston

研究点 (1)

Loading locations...

相似试验